메뉴 건너뛰기




Volumn 90, Issue 5, 2011, Pages 611-612

Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; IRON; THALIDOMIDE; TRANEXAMIC ACID;

EID: 79956101052     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-010-1063-5     Document Type: Letter
Times cited : (20)

References (6)
  • 1
    • 33747837492 scopus 로고    scopus 로고
    • Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab [5]
    • DOI 10.1007/s00277-006-0147-8
    • Flieger D, Hainke S, Fischbach W (2006) Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab. Ann Hematol 85(9):631-632 (Pubitemid 44283088)
    • (2006) Annals of Hematology , vol.85 , Issue.9 , pp. 631-632
    • Flieger, D.1    Hainke, S.2    Fischbach, W.3
  • 2
    • 65649124507 scopus 로고    scopus 로고
    • Bevacizumab in hereditary hemorrhagic telangiectasia
    • Bose P, Holter JL, Selby GB (2009) Bevacizumab in hereditary hemorrhagic telangiectasia. N Engl J Med 360(20):2143-2144
    • (2009) N Engl J Med , vol.360 , Issue.20 , pp. 2143-2144
    • Bose, P.1    Holter, J.L.2    Selby, G.B.3
  • 3
    • 33645226078 scopus 로고    scopus 로고
    • New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia
    • Mahoney EJ, Shapshay SM (2006) New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia. Am J Rhinol 20(1):87-90
    • (2006) Am J Rhinol , vol.20 , Issue.1 , pp. 87-90
    • Mahoney, E.J.1    Shapshay, S.M.2
  • 4
    • 1842505675 scopus 로고    scopus 로고
    • Hormonal and Antihormonal Therapy for Epistaxis in Hereditary Hemorrhagic Telangiectasia
    • DOI 10.1097/00005537-200404000-00021
    • Jameson JJ, Cave DR (2004) Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 114(4):705-709 (Pubitemid 38548784)
    • (2004) Laryngoscope , vol.114 , Issue.4 , pp. 705-709
    • Jameson, J.J.1    Cave, D.R.2
  • 5
    • 63249096929 scopus 로고    scopus 로고
    • Antiestrogen therapy for hereditary hemorrhagic telangiectasia: A double-blind placebo-controlled clinical trial
    • Yaniv E, Preis M, Hadar T, Shvero J, Haddad M (2009) Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial. Laryngoscope 119 (2):284-288
    • (2009) Laryngoscope , vol.119 , Issue.2 , pp. 284-288
    • Yaniv, E.1    Preis, M.2    Hadar, T.3    Shvero, J.4    Haddad, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.